This inventor holds 2 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1977
Title: Mitsutaka Kawazu: Innovator in Pharmaceutical Chemistry
Introduction
Mitsutaka Kawazu is a notable inventor based in Urawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antimicrobial agents. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Kawazu's latest patents include innovative formulations and processes. One of his patents focuses on penicillins and processes for preparing the same. This patent describes a compound with a specific formula, where R¹ can be hydrogen or hydroxy, and R² is a group that includes various chemical structures. The compound and its pharmaceutically acceptable salts are recognized for their utility as antimicrobial agents. Another patent involves a process for preparing a cyclodextrin derivative, which is reacted with specific sulfonyl compounds, showcasing his expertise in complex chemical reactions.
Career Highlights
Kawazu is associated with Tanabe Seiyaku Company, Limited, where he has been able to apply his innovative ideas in a professional setting. His work has contributed to advancements in pharmaceutical formulations, enhancing the efficacy of treatments available in the market.
Collaborations
Throughout his career, Kawazu has collaborated with notable colleagues, including Mitsuyoshi Wagatsuma and Satoshi Ohshima. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Mitsutaka Kawazu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antimicrobial agents and other pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile